Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors

被引:0
|
作者
Michail Sitkovsky
Dmitriy Lukashev
机构
[1] New England Inflammation and Tissue Protection Institute,
[2] Northeastern University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
It should be appreciated that the oxygen tensions in inflamed tissues, and even in normal tissues, are usually low (that is, these tissues are hypoxic).The molecular mechanisms that ensure adaptation to hypoxia are operational in immune cells, thereby enabling immune surveillance in all tissue microenvironments and preventing 'safe shelters' for pathogens.Activated immune cells mainly rely on glycolysis, rather than on oxidative phosphorylation, as a source of energy.Hypoxia can regulate the activity of immune cells by promoting accumulation of adenosine and by stabilizing hypoxia-inducible factor 1α (HIF1α).Inhibition of HIF1 might have different effects in various types of immune cell. HIF1α deficiency in myeloid cells results in reduced inflammation. By contrast, in T cells, HIF1α is thought to be a negative regulator of activity.HIF1 is a promising therapeutic target for modulating immune responses. Inhibition or upregulation of HIF1α might induce or reduce inflammation depending on the type of immune response.
引用
收藏
页码:712 / 721
页数:9
相关论文
共 50 条
  • [11] The Reverse Warburg Effect Is Associated with Fbp2-Dependent Hif1α Regulation in Cancer Cells Stimulated by Fibroblasts
    Duda, Przemyslaw
    Janczara, Jakub
    McCubrey, James A.
    Gizak, Agnieszka
    Rakus, Dariusz
    CELLS, 2020, 9 (01)
  • [12] HIF1α regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis
    Amarilio, Roy
    Viukov, Sergey V.
    Sharir, Amnon
    Eshkar-Oren, Idit
    Johnson, Randall S.
    Zelzer, Elazar
    DEVELOPMENT, 2007, 134 (21): : 3917 - 3928
  • [13] eIF3a mediates HIF1α-dependent glycolytic metabolism in hepatocellular carcinoma cells through translational regulation
    Miao, Bisi
    Wei, Chuanyuan
    Qiao, Zijun
    Han, Weiyu
    Chai, Xiaoqiang
    Lu, Jiacheng
    Gao, Chao
    Dong, Ruizhao
    Gao, Dongmei
    Huang, Cheng
    Ke, Aiwu
    Zhou, Jian
    Fan, Jia
    Shi, Guoming
    Lan, Fei
    Cai, Jiabin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (05): : 1079 - 1090
  • [14] Regulation of A(1) adenosine receptors by amiodarone and electrical stimulation in rat myocardial cells in vitro
    ElAni, D
    Jacobson, KA
    Shainberg, A
    BIOCHEMICAL PHARMACOLOGY, 1997, 54 (05) : 583 - 587
  • [15] Accumulation and nuclear import of HIF1 alpha during high and low oxygen concentration in skeletal muscle cells in primary culture
    Kubis, HP
    Hanke, N
    Scheibe, RJ
    Gros, G
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2005, 1745 (02): : 187 - 195
  • [16] Adenosine A1 receptors contribute to immune regulation after neonatal hypoxic ischemic brain injury
    Max Winerdal
    Malin E. Winerdal
    Ying-Qing Wang
    Bertil B. Fredholm
    Ola Winqvist
    Ulrika Ådén
    Purinergic Signalling, 2016, 12 : 89 - 101
  • [17] Adenosine A1 receptors contribute to immune regulation after neonatal hypoxic ischemic brain injury
    Winerdal, Max
    Winerdal, Malin E.
    Wang, Ying-Qing
    Fredholm, Bertil B.
    Winqvist, Ola
    Aden, Ulrika
    PURINERGIC SIGNALLING, 2016, 12 (01) : 89 - 101
  • [18] Immune regulation via non-immunological receptors on immunocompetent cells: Strong immunosuppression, induced by adenosine and epinephrine
    Leskovar, P
    Siegmund, F
    Mattele, N
    Reithmeier, T
    Hesch, H
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 53 - 53
  • [19] Aging changes the expression of adenosine receptors, insulin-like growth factor 1 (IGF1), and hypoxia-inducible factor 1α (HIF1α) in hypothalamic astrocyte cultures
    Santos, Camila Leite
    Bobermin, Larissa Daniele
    Quincozes-Santos, Andre
    AGING BRAIN, 2024, 5
  • [20] A1 ADENOSINE RECEPTORS IN THE HUMAN FAT-CELL - TISSUE DISTRIBUTION AND REGULATION OF RADIOLIGAND BINDING
    LARROUY, D
    GALITZKY, J
    LAFONTAN, M
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 206 (02): : 139 - 147